HUDSON, Wis.--(BUSINESS WIRE)--Phillips-Medisize, a Molex company and global leader in the design, development and commercial manufacturing of Connected Health solutions announced today the expansion of its Connected Health team and its global Front-End Innovation (FEI) footprint.
The Connected Health solutions are driven by its FEI team, which has expanded because of increased demand for device innovation and Connected Health services. Industry experts from leading consulting, medtech and biopharma organizations have recently joined Phillips-Medisize’s Connected Health leadership team including Kevin Deane, former Partner at PA Consulting, Andrew Tubb, former Director of Global Marketing at Sanofi, Chris Conger, former VP R&D at IntriCon and Neil Williams, Health IT expert previously at TotalMobile, Microsoft and Hospira.
“Together, we bring more than 80 years’ experience across all facets of Connected Health, from deep electronics and communications technology to the impact of digital for our customers’ global sales and marketing plans,” says Kevin Deane, VP of Front-End Innovation at Phillips-Medisize. “To us, successful Connected Health solutions are built on three underlying foundations: robust technology, solid business planning and empathetic patient engagement. The mission of FEI is to build these into all of our Connected Health projects, and to ensure our investments in new capabilities, technologies, facilities and staff continue to add to this picture and provide increased value to our clients.”
The FEI team works with clients to develop differentiated and drug-specific strategies to better define clients’ Connected Health value propositions and enhance return on investment. Historically, the Phillips-Medisize FEI team has served globally from its Cambridge, UK, and Struer, DK, offices. Due to client demand in North America, today it announces planned FEI additions to its Fremont, Calif., office, with future expansions slated for its Hudson, WI office and a Massachusetts location to be finalized later this year.
“Our FEI expansion, in terms of expertise and footprint, is key for Phillips-Medisize. We remain committed to providing customers consistent and reliable device innovation and Connected Health strategy consulting — no matter where in the world they’re located,” said Deane. “Our goal is to leverage innovation, development and Connected Health sources around the world to deliver the best to our customers and, in turn, their patients.”
The Phillips-Medisize FEI team is supported by its main Global Innovation and Development (GID) centers in Europe and the US, and a satellite center in Suzhou, China, with targeted Connected Health and electronics production facilities in North America, Europe, and Asia, ensuring customers around the globe have access to industry-leading capabilities.
About Phillips-Medisize:
Phillips-Medisize, LLC, a Molex company, is an end-to-end provider of innovation, development, manufacturing, and post-launch services to the pharmaceutical, diagnostics, medical device and specialty commercial markets. Post-launch services include Connected Health app and data services. Backed by the combined global resources of Molex and its parent company Koch Industries, Phillips-Medisize’s core advantage is the knowledge of its people to integrate design, molding, electronics, and automation, providing innovative, high-quality manufacturing solutions. For more information, please visit www.phillipsmedisize.com or www.molex.com.
